The SCOPE Summit 2025 addressed key areas in clinical trials: budget negotiations, protocol design, and AI integration. Clinical Trial Budget Negotiations: The summit addressed unresponsive sites and budget discrepancies3. It promoted clear communication, thorough feasibility assessments, and flexible fair market value (FMV) parameters to improve negotiation efficiency and fairness. Enhancing Clinical Trial Protocol Design: Collaboration between Mass General Brigham (MGB), AstraZeneca, and Evinova focuses on improving communication, data utilization, and patient-centric approaches MGB’s HERO initiative and AstraZeneca’s patient partnership program were highlighted as ways to enhance study feasibility, patient engagement, and recruitment. AI Integration: The summit emphasized the transformative role … Continue reading Key Takeaways from SCOPE Summit 2025: Budget Negotiations, Protocol Design, and AI in Clinical TrialsSCOPE Summit Summary